Stay updated on Benralizumab in Hypereosinophilic Syndrome Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.

Latest updates to the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page
- Check3 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a backend update to the page. The change does not alter visible study content or user-facing features.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange Detected- Adds a new publication reference to the Publications section for a study on benralizumab in PDGFRA-negative hypereosinophilic syndrome, including authors, title, journal, and DOI. - This provides broader literature context on the drug and condition within the study record.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision identifier was updated from v3.6.0 to v3.6.3, indicating a software or content system update rather than a change to study details.SummaryDifference0.1%

- Check46 days agoChange DetectedNew metadata labels Last verified and Last known status have been added to the page. The page also introduces user guidance links (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label along with a revision note (Revision: v3.6.0).SummaryDifference1%

- Check53 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a recent deployment or update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a minor platform update without changes to the displayed information.SummaryDifference0.1%

Stay in the know with updates to Benralizumab in Hypereosinophilic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.